Explore

Trendline Trendline
Viridian Therapeutics Launches Public Offerings to Raise Funds for Autoimmune and Rare Disease Treatments

Viridian Therapeutics Launches Public Offerings to Raise Funds for Autoimmune and Rare Disease Treatments

Viridian Therapeutics Launches Public Offerings to Raise Funds for Autoimmune and Rare Disease Treatments
Trendline Trendline
Travere Therapeutics Proposes $400 Million Convertible Senior Notes Offering to Refinance 2029 Notes

Travere Therapeutics Proposes $400 Million Convertible Senior Notes Offering to Refinance 2029 Notes

Travere Therapeutics Proposes $400 Million Convertible Senior Notes Offering to Refinance 2029 Notes
Trendline Trendline
North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035

North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035

North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035
Trendline Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Trendline Trendline
Odyssey Therapeutics Sets Terms for $225 Million IPO Amid Resurgent Biotech Market

Odyssey Therapeutics Sets Terms for $225 Million IPO Amid Resurgent Biotech Market

Odyssey Therapeutics Sets Terms for $225 Million IPO Amid Resurgent Biotech Market
Trendline Trendline
Zura Bio Announces Inducement Grants to New Employees Under Nasdaq Rule

Zura Bio Announces Inducement Grants to New Employees Under Nasdaq Rule

Zura Bio Announces Inducement Grants to New Employees Under Nasdaq Rule
Trendline Trendline
IQVIA Reports Strong Q1 2026 Financial Results with Revenue Growth

IQVIA Reports Strong Q1 2026 Financial Results with Revenue Growth

IQVIA Reports Strong Q1 2026 Financial Results with Revenue Growth
Trendline Trendline
Vertex Pharmaceuticals Reports Strong Q1 2026 Financial Results with 8% Revenue Growth

Vertex Pharmaceuticals Reports Strong Q1 2026 Financial Results with 8% Revenue Growth

Vertex Pharmaceuticals Reports Strong Q1 2026 Financial Results with 8% Revenue Growth
Trendline Trendline
Stevanato Group Announces Participation in Three Major Investor Conferences in the U.S.

Stevanato Group Announces Participation in Three Major Investor Conferences in the U.S.

Stevanato Group Announces Participation in Three Major Investor Conferences in the U.S.
Trendline Trendline
BioNTech to Close Manufacturing Plants, Impacting 1,860 Jobs

BioNTech to Close Manufacturing Plants, Impacting 1,860 Jobs

BioNTech to Close Manufacturing Plants, Impacting 1,860 Jobs
Trendline Trendline
Stevanato Group to Participate in Three Major Investor Conferences

Stevanato Group to Participate in Three Major Investor Conferences

Stevanato Group to Participate in Three Major Investor Conferences
Trendline Trendline
INOVIO to Announce Q1 2026 Financial Results with Live Webcast

INOVIO to Announce Q1 2026 Financial Results with Live Webcast

INOVIO to Announce Q1 2026 Financial Results with Live Webcast